NCT06535009View on ClinicalTrials.gov

Study of ONO-7914 Alone and in Combination With ONO-4538 in Patients With Solid Tumors

PHASE1TerminatedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

February 8, 2022

Primary Completion Date

February 26, 2025

Study Completion Date

February 26, 2025

Conditions
Solid Tumor
Interventions
DRUG

ONO-7914

Specified dose on specified days

DRUG

ONO-4538

Specified dose on specified days

Trial Locations (1)

Unknown

Cancer Institute Hospital of JFCR, Koto-ku

Sponsors
All Listed Sponsors
lead

Ono Pharmaceutical Co. Ltd

INDUSTRY